The Claim
In patients with Hashimoto’s thyroiditis, plasma selenium levels are suboptimal (median 85.0 µg/L) relative to the thresholds associated with maximal selenoprotein activity (≥95–115 µg/L), despite no statistically significant difference in plasma selenium levels compared to healthy controls, indicating a potential widespread selenium insufficiency in this population that may not be detectable through group-level comparisons alone.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
People with Hashimoto’s thyroiditis tend to have lower levels of selenium in their blood than what is needed for optimal function of selenium-dependent proteins, even though their levels are not statistically different from healthy individuals, suggesting that group comparisons may miss individual insufficiency.
See the scientific wording
In patients with Hashimoto’s thyroiditis, plasma selenium levels are suboptimal (median 85.0 µg/L) compared to thresholds associated with maximal selenoprotein activity (≥95–115 µg/L), despite no significant difference from healthy controls, suggesting widespread selenium insufficiency in this population that may not be captured by group comparisons alone.
What the research says
1 studyStudy: Plasma levels of Th17‐associated cytokines and selenium status in autoimmune thyroid diseases
Even though people with Hashimoto’s had similar selenium levels on average as healthy people, those levels were still too low to help the body’s protective proteins work their best — meaning many patients might be quietly deficient.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.